Your browser doesn't support javascript.
loading
Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03).
Kobayashi, Kokoro; Masuda, Norikazu; Mizuno, Toshiro; Miura, Kayo; Tokuda, Yutaka; Yoshinami, Tetsuhiro; Kawaguchi, Hidetoshi; Ohtani, Shoichiro; Saeki, Toshiaki; Toi, Masakazu; Takeuchi, Masahiro; Ito, Yoshinori.
Affiliation
  • Kobayashi K; Department of Breast Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan. kokorok-medicaloncology@memoad.jp.
  • Masuda N; Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Mizuno T; Department of Surgery, Breast Oncology, NHO Osaka National Hospital, Osaka, Japan.
  • Miura K; Department of Medical Oncology, Mie University Hospital, Tsu, Japan.
  • Tokuda Y; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Yoshinami T; Breast Center, Seirei Yokohama Hospital, Yokohama, Japan.
  • Kawaguchi H; Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Ohtani S; Department of Breast Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Saeki T; Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Toi M; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Takeuchi M; Department of Breast Surgery, Graduate School of Medicine, Kyoto University Hospital, Kyoto, Japan.
  • Ito Y; Graduate School of Mathematical Sciences, The University of Tokyo, Tokyo, Japan.
Breast Cancer Res Treat ; 201(3): 409-415, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37480384

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Breast Neoplasms Type of study: Observational_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Breast Neoplasms Type of study: Observational_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Document type: Article Affiliation country: Japan